XTalks
APRIL 29, 2025
Faba bean protein, derived from Vicia faba , is emerging as a high-quality, sustainable plant-based protein that is rapidly gaining traction in the food industry. Faba beans contain up to 30% protein and an impressive amino acid profile that rivals that of both soy and animal proteins. This makes it a versatile alternative for formulations ranging from bakery and dairy alternatives to meat substitutes.
Worldwide Clinical Trials
APRIL 29, 2025
On the last day of February every year is Rare Disease Day , a dedicated day to celebrate the rare disease community, including patients, families, caregivers, clinicians, researchers, regulators, and more. The day inspires multiple events, such as fundraisers and scientific symposia, to bring together all the critical stakeholders who tirelessly work to make life better for those affected by rare diseases.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
MAY 2, 2025
Sales of the company’s copycat to J&J’s blockbuster medicine reached $150 million in the first quarter, adding to a surge in revenue for Amgen's biosimilar business.
AuroBlog - Aurous Healthcare Clinical Trials blog
APRIL 30, 2025
In a significant leap towards advancing Indias capabilities in cancer research and personalized healthcare, the Indian Council of Medical Research (ICMR)-National Institute of Cancer Prevention and Research (NICPR) under the Department of Health Research (DHR) has announced a DHR-sponsored intensive training course titled Advent of Omics Technologies in Precision Diagnostics and Targeted Therapeutics.
Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group
Let’s face it—most ethics and compliance trainings aren’t winning awards for engagement. But that doesn’t mean they can’t be effective, relevant, and maybe even enjoyable! Join expert Brian Richardson for a dynamic session on how to breathe new life into your ethics and compliance training programs. You’ll discover creative strategies to turn traditionally dry topics into meaningful learning experiences that resonate and drive real change.
Pharmaceutical Technology
MAY 2, 2025
The post-traumatic stress disorder (PTSD) market is expected to grow at a high compound annual growth rate of 16.1% from $1.2bn in 2024 to $5.5bn by 2034 across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and Australia), according to leading data and analytics company GlobalDatas recent report, Post-Traumatic Stress Disorder: Opportunity Assessment and Forecast.
Rethinking Clinical Trials
APRIL 30, 2025
In this Friday’s PCT Grand Rounds, Roland RJ van Kimmenade will present “Fluid Restriction in Heart Failure Versus Liberal Fluid Uptake: The FRESH-UP Study.” The Grand Rounds session will be held on Friday, May 2, 2025, at 1:00 pm eastern. Van Kimmenade is a cardiologist at Radboud University Medical Center in Nijmegen, Netherlands.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
XTalks
MAY 2, 2025
New data for Boehringer Ingelheims investigational oncology candidate, zongertinib, shows sustained clinical benefits in non-small cell lung cancer (NSCLC) patients with HER2 mutations in the tyrosine kinase domain (TKD). Updated findings from the Phase Ib Beamion LUNG-1 trial included durability of response, building on the clinical evidence supporting zongertinibs efficacy.
Pharmaceutical Technology
MAY 2, 2025
As scientists explore treating genetic disorders before birth, the promise of foetal gene therapy is growingbut there are hurdles to overcome.
ACRP blog
APRIL 29, 2025
Signature Series speakers took on more of the clinical research enterprises big picture topics at ACRP 2025 on Saturday (April 26), focusing in the morning on the implications for clinical trials teams of the recently updated ICH E6(R3) Guideline for Good Clinical Practice (GCP) from the International Council for Harmonization , and in the afternoon on how seasoned professionals are enacting meaningful change in their organizations for the betterment of trial implementation and management.
Bio Pharma Dive
MAY 1, 2025
The company removed experimental drugs for Alzheimer’s, migraine and pain from its pipeline to focus more resources on “core therapeutic areas” and “high value” programs.
Advertisement
Enhancing Transparency & Efficiency Throughout the Trial Lifecycle for AI Readiness
Rethinking Clinical Trials
MAY 2, 2025
Speaker Ming Tai-Seale, PhD, MPH Professor Departments of Family Medicine and Medicine (Bioinformatics) University of California San Diego School of Medicine Director of UC San Diego Learning Health Systems Science Center Slides Keywords Electronic Health Record; Artificial Intelligence; MyChart; Patient Messages; Large Language Models; Clinician Well-Being; Mental Health Key Points Physician work is increasingly centered around the electronic health record (EHR).
Pharmaceutical Technology
MAY 2, 2025
The UK MHRA has granted marketing authorisation to Bavarian Nordic's Vimkunya vaccine for preventing the chikungunya virus.
ACRP blog
APRIL 26, 2025
With recent federal actions upending business as usual for many stakeholders in the clinical research enterprise, some of its thought leaders pondered the big question of Where does clinical research go from here? during Fridays (April 25) first Signature Series gathering at ACRP 2025 in New Orleans. After the heartfelt session closed with a Big Easy-style second line jazz band sendoff, an expert lineup of educational session presenters held forth on an array of vital topics for members of the i
Bio Pharma Dive
APRIL 28, 2025
Pharmaceutical companies are turning to integrated RWD approaches to overcome challenges in rare disease research.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
XTalks
APRIL 30, 2025
HeartBeams synthesized 12-lead electrocardiogram (ECG) technology has met its clinical endpoints in the VALID-ECG pivotal study, a key step toward FDA clearance. The results, presented by Dr. Thomas Deering of Piedmont Heart Institute, lent credence to HeartBeams ability to deliver clinically reliable ECG data through a portable, patient-operated system.
Pharmaceutical Technology
MAY 2, 2025
Pliant is slashing 45% of its workforce in a move to minimise costs and preserve cash reserves.
pharmaphorum
MAY 2, 2025
Shares in Eli Lilly have weakened after pharmacy benefit manager CVS Health said it would no longer cover its weight-loss therapy Zepbound.
Bio Pharma Dive
MAY 1, 2025
The deal could expand access to its in-demand obesity drug at the expense of Eli Lilly, whose shares fell by double digits on Thursday.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
ACRP blog
APRIL 30, 2025
From the moment one begins immersing oneself in the full education, networking, and workforce development advocacy experience that an Association of Clinical Research Professionals (ACRP) conference encompasses, theres almost limitless possibilities for meeting and learning from the new and exciting personalities one may encounter. Did you know that at ACRP 2025 (going on right now in New Orleans), you could meet such attendeeswhether they are ACRP members, certificants, presenters, leaders, ex
Pharmaceutical Technology
MAY 2, 2025
4D Molecular Therapeutics (4DMT) has received the regenerative medicine advanced therapy (RMAT) designation from the FDA for 4D-150.
Pharma Tutor
MAY 2, 2025
List of Drug patent expiration 2025 admin Fri, 05/02/2025 - 14:05 Drug patent expiration presents a significant opportunity for the launch of generic medications, which can dramatically alter market dynamics. When a branded drug's patent expires, it opens the door for generic manufacturers to produce and sell bioequivalent versions at a lower cost, leading to increased competition and reduced prices.
Bio Pharma Dive
MAY 1, 2025
Siren Biotechnology is trying to raise $5 million via the type of crowdfunding round that’s rarely used by young drugmakers.
Speaker: Amie Phillips Pablo, VP, Corporate Compliance & Privacy Officer at Novo Nordisk
Medical Xpress
APRIL 26, 2025
As the opioid crisis continues, the number of babies born with neonatal opioid withdrawal syndrome (NOWS)a condition that affects infants whose mothers used opioids during pregnancyhas risen 5-fold over the past 20 years. According to the Centers for Disease Control (CDC), there are 20,000 infants a year in the United States born with signs of NOWS.
Pharmaceutical Technology
MAY 2, 2025
The US HHS has launched a $500m initiative to accelerate the development of universal vaccines targeting viruses with pandemic potential.
pharmaphorum
MAY 2, 2025
A new policy from the NIH in the US will cut billions of dollars of funding for research organisations and hospitals outside the US.
Bio Pharma Dive
APRIL 29, 2025
The delay for Stealth Biotherapeutics comes amid a heightened focus on the impact FDA job cuts might have on drug reviews.
Advertisement
Download this comprehensive guide to AI and ML in the R&D Laboratory Setting.
Imperical Blog
APRIL 29, 2025
Effective clinical trial project managers do more than just keep tasks on schedule; they play a crucial role in ensuring project success and operational efficiency. Organizations that adopt project management practices achieve a 92% success rate in meeting their project goals and experience 28 times… The post What makes an effective clinical trial project manager?
Pharmaceutical Technology
MAY 2, 2025
Repare Therapeutics has entered into an out-licensing agreement with Canadian biotechnology firm DCx for discovery platforms and IP.
pharmaphorum
MAY 2, 2025
A planning application has been filed to invest 1bn in "the world's leading centre for cancer research and treatment" in London.
Bio Pharma Dive
APRIL 28, 2025
Sen. Bill Cassidy’s report calls on Congress to improve the transparency of the drug discount program in a move praised by pharmaceutical companies and criticized by hospitals.
Expert insights. Personalized for you.
64 
Let's personalize your content